Armour Thyroid vs Levothyroxine for Hashimoto's (2026)

Armour Thyroid vs levothyroxine comes down to one question: does adding T3 help you feel better than T4 alone? For most people with Hashimoto's, the answer from blinded trials is no. Levothyroxine and desiccated thyroid produce the same average scores on symptoms, mood and memory (Hoang et al., 2013; Shakir et al., 2021). But averages hide people. Roughly half of trial participants preferred desiccated thyroid, and the most symptomatic patients on levothyroxine improved when switched. Levothyroxine remains the guideline standard. T4 plus T3 combination therapy and natural desiccated thyroid (NDT) are second-line options for selected patients, started and monitored by a prescriber.

This guide compares the three main options, explains why the T4:T3 ratio matters, covers the FDA's 2025 and 2026 actions on NDT, and lays out what a safe, supervised switch looks like. If you are still deciding whether levothyroxine is working at all, start with our guide to natural alternatives to levothyroxine, which covers absorption fixes and supporting supplements. This article stays on the prescription choice.

How to Read the Evidence Grades in This Article

The grades rate the strength of evidence for each medication strategy in hypothyroidism caused by Hashimoto's. They do not say which pill is right for you. That depends on your labs, your heart, your age, your pregnancy plans and how you respond.

What Is in Each Thyroid Medication?

Your thyroid makes two hormones. T4 (thyroxine) is the storage form. T3 (triiodothyronine) is the active form that switches on genes in nearly every cell. Most of your T3 is made outside the thyroid, in the liver, muscle, brain and other tissues, by enzymes called deiodinases that strip one iodine atom off T4.

As Hashimoto's slowly destroys thyroid tissue, both outputs fall. The three treatment strategies replace them differently.

Levothyroxine (T4 only) [Grade A]

Levothyroxine is synthetic T4, sold as Synthroid, Levoxyl, Unithroid, Euthyrox, Tirosint and many generics. It relies on your tissues to convert T4 to T3. Its half-life of about a week produces stable blood levels with a single daily dose.

The American Thyroid Association's 2014 guideline names levothyroxine the treatment of choice for hypothyroidism (Jonklaas et al., 2014, Thyroid). The European Thyroid Association's 2012 guideline says the same and calls combination therapy experimental (Wiersinga et al., 2012). If you have Hashimoto's rather than another cause of hypothyroidism, the pill choice is the same; the difference lies in managing the immune side.

Liothyronine (synthetic T3) [Grade B as an add-on]

Liothyronine is synthetic T3, sold as Cytomel and generics. Doctors rarely use it alone for long-term treatment. It is usually added in small doses to a reduced levothyroxine dose, which is what "combination therapy" means in the research.

T3 acts faster and harder than T4. The 2021 joint consensus of the American, British and European thyroid associations puts the pharmacological equivalence at roughly 1:3, meaning 1 mcg of T3 does the work of about 3 mcg of T4 (Jonklaas et al., 2021, Thyroid).

Natural Desiccated Thyroid (Armour, NP Thyroid) [Grade B, with caution]

NDT is dried, powdered pig thyroid gland pressed into tablets. Armour Thyroid is the best-known brand; NP Thyroid is the other widely prescribed U.S. product. Doses are expressed in grains. One grain (60 mg) of Armour contains 38 mcg T4 and 9 mcg T3, according to its label.

NDT was the only thyroid treatment for most of the 20th century. Synthetic levothyroxine replaced it in the 1970s because it offered consistent potency and could be dosed precisely.

The Ratio Problem: Why 4.2:1 Is Not 14:1

A healthy human thyroid releases T4 and T3 in a ratio of roughly 14:1, about 85 to 100 mcg of T4 and 5 to 6.5 mcg of T3 a day (Jonklaas et al., 2021). One grain of NDT delivers 38 mcg T4 and 9 mcg T3, a ratio of about 4.2:1. Pigs make proportionally more T3 than people do.

So NDT gives you roughly three times the T3 share your own gland would supply. The 2021 consensus states plainly that DTE "would not allow" a physiological free T3 to free T4 ratio to be achieved. The ETA 2012 guideline, by contrast, suggests that combination therapy start at a T4:T3 ratio between 13:1 and 20:1 by weight, which sits close to human output (Wiersinga et al., 2012).

The ratio has two practical effects. First, T3 from any tablet reaches peak blood levels about 2 hours after you swallow it, and a single dose can raise T3 by up to 40% (Jonklaas et al., 2021). The higher the T3 share, the bigger that swing. Second, extra T3 suppresses TSH more, so a person on NDT can show a low-normal or low TSH while free T4 sits at the bottom of the range.

Some people feel that swing as clearer thinking and more energy. Others feel it as palpitations, sweating, anxiety or poor sleep a couple of hours after the morning dose.

NDT vs Levothyroxine: What the Trials Show

Three randomized trials have compared desiccated thyroid with levothyroxine directly. None found NDT better on average. Two found that many patients prefer it.

Hoang et al. 2013: the first blinded crossover

Hoang and colleagues randomized 70 adults on stable levothyroxine to 16 weeks of desiccated thyroid extract (DTE) and 16 weeks of levothyroxine, in random order, with patients and investigators blinded (Hoang et al., 2013, J Clin Endocrinol Metab).

• Symptoms and neurocognitive scores did not differ between treatments.
• Participants weighed about 3 lb less on DTE (172.9 vs 175.7 lb).
• 48.6% preferred DTE, 18.6% preferred levothyroxine and 32.9% had no preference.
• Patients who preferred DTE scored better on general health and thyroid symptom questionnaires while taking it.

The authors concluded that DTE did not improve quality of life overall but "may be relevant for some hypothyroid patients."

Shakir et al. 2021: three arms, 22 weeks each

The same group then ran a larger double-blind crossover. Seventy-five patients completed 22 weeks each of levothyroxine, levothyroxine plus liothyronine, and DTE (Shakir et al., 2021, J Clin Endocrinol Metab). About 61% had autoimmune (Hashimoto's) hypothyroidism.

Across the whole group, symptom, depression, wellbeing and memory scores were statistically identical. Rank-one preference split 45% for DTE, 32% for the combination and 23% for levothyroxine, a difference that did not reach significance.

The signal appeared in the third of participants who felt worst on levothyroxine, identified by the highest symptom and mood scores. When they switched to either T4 plus T3 or DTE, their scores improved significantly, and they preferred the T3-containing treatments. Results did not differ by the cause of hypothyroidism.

The authors flagged the limits honestly. The subgroup analysis was not a primary outcome, was not corrected for multiple comparisons, and could partly reflect regression to the mean. Heart rate ran slightly higher on DTE (73.7 vs 71.5 beats per minute).

The Armour Thyroid trial (NCT04124705)

Armour's manufacturer sponsored a 284-person, double-blind, randomized trial to test whether Armour could hold TSH in range as reliably as levothyroxine after a switch. Results were posted to ClinicalTrials.gov in May 2024.

At the end of titration and stabilization, 60.8% of the Armour group had a sustained normal TSH, compared with 75.9% on levothyroxine. The difference was minus 15.2 percentage points, with a 95% confidence interval running from minus 26.1 to minus 4.2. Because the entire interval sits below zero, Armour was measurably worse at keeping TSH in range. This result comes from the registry and, to our knowledge, has not appeared in a peer-reviewed journal. The trial measured TSH control, not how people felt.

T3 Medication for Hashimoto's: Liothyronine Combination Therapy

Combination therapy adds synthetic liothyronine to a reduced levothyroxine dose. It reaches the same goal as NDT, supplying some T3 directly, with two advantages: both drugs are FDA-approved, and the ratio can be set by the prescriber.

What the meta-analysis found [Grade B]

A 2021 systematic review pooled 18 studies comparing combination therapy with levothyroxine alone (Millan-Alanis et al., 2021, Thyroid). On standardized measures of quality of life, fatigue, depression and psychological distress, the two approaches performed the same, at low-to-moderate certainty. Patient preference told a different story: 43% chose combination therapy, 23% chose levothyroxine and 30% had no preference. Adverse event rates looked similar.

What the thyroid societies say

The 2021 ATA/BTA/ETA consensus noted that 14 clinical trials had failed to show a consistent benefit, yet patients reporting benefit keep the question alive. Its authors agreed there is equipoise for a new trial, meaning genuine uncertainty, and set out how future studies should be designed: patients dissatisfied on adequate levothyroxine, twice-daily or slow-release T3, and enough power to test genetic subgroups (Jonklaas et al., 2021).

The ETA 2012 guideline allows a trial of combination therapy in adherent patients with persistent complaints despite a normal TSH, after associated autoimmune diseases are excluded, under a specialist, and stopped if there is no improvement after 3 months (Wiersinga et al., 2012). The UK's NICE guidance does not recommend routine liothyronine but does not rule it out (Leese, 2020).

Is T3 safe long term?

Safety data are more reassuring than many patients are told. A 17-year Scottish population study compared 400 liothyronine users with 33,955 people on levothyroxine alone. T3 users had no increase in cardiovascular disease (HR 1.04), atrial fibrillation (HR 0.91) or fractures (HR 0.79) (Leese et al., 2016, Clin Endocrinol). The same study did find more new antipsychotic prescriptions among T3 users, an association the authors could not explain.

A 2025 meta-analysis covering 21 RCTs and cohort data on more than 630,000 people found no increased risk of atrial fibrillation, heart failure or stroke with regulated T3 use. Serious adverse events were reported mainly with unregulated or compounded T3 (Bahl et al., 2025, J Clin Endocrinol Metab). These are observational data in people whose doctors chose T3, so they cannot prove T3 is risk-free, especially at doses that push TSH well below range.

Does DIO2 Genetics Predict Who Needs T3? [Grade C]

Type 2 deiodinase (DIO2) converts T4 to T3 inside cells, including in the brain. A common variant, known as Thr92Ala (rs225014), produces a slower enzyme in lab studies. The theory is simple: people with two copies convert less T4 inside their brain cells and may need T3 supplied directly.

The key human study came from the WATTS trial. Among 552 people on levothyroxine, the 16% who carried two copies of the variant had worse baseline wellbeing scores and improved more on combination therapy than on T4 alone (by 2.3 GHQ-12 points at 3 months). Their blood thyroid levels looked no different (Panicker et al., 2009, J Clin Endocrinol Metab). The authors called for replication.

Replication has been patchy. In Shakir 2021, outcomes did not differ by DIO2 genotype, although the homozygous group was too small to analyze properly. The 2021 consensus concluded that the clinical impact of Thr92Ala is "currently unclear" and asked that future trials be powered to test it.

DIO2 testing is sold direct to consumers. A result may start a conversation with your doctor, but no guideline uses it to choose a medication. Reverse T3 is another marker often used to justify T3, and it carries its own caveats.

The "Pork Antigen" Myth in Hashimoto's

Two opposite claims circulate in patient communities. One says pig thyroid proteins in NDT "feed" the autoimmune attack and raise TPO and thyroglobulin antibodies. The other says NDT calms antibodies because it is "natural."

Neither claim has published support. We could find no controlled study showing that NDT raises or lowers thyroid antibodies in Hashimoto's. Hoang 2013 and Shakir 2021, the two blinded NDT trials, did not report antibody outcomes at all. The question is untested, not settled. Grade it C.

Biology gives some perspective. TPO and thyroglobulin antibodies target proteins in your thyroid tissue. The tablet is swallowed and digested, and the meaningful active ingredients are the hormones themselves, which are chemically identical in pigs and humans. That makes a large antibody effect unlikely, though not impossible.

What does move antibodies is the immune side of Hashimoto's: selenium status, vitamin D, gluten in people with celiac disease, postpartum shifts, and the natural course of the disease. Our guides to what your TPO and Tg antibody numbers mean and to selenium for Hashimoto's cover what the evidence supports. Choose a hormone replacement for how well it replaces hormone. Treat the autoimmunity separately.

NP Thyroid vs Armour: Brands, Recalls and FDA Status

NP Thyroid and Armour Thyroid carry the same labeled content per grain. The differences are manufacturer, fillers, price, availability and quality track record.

Recall history

Potency problems have hit several NDT products:

• RLC Labs, 2020: Nature-Throid and WP Thyroid were recalled after FDA testing found lots with as little as 87% of labeled T3 or T4. Both products later left the market.
• Acella NP Thyroid, September 2020: one lot each of the 15 mg and 120 mg tablets was recalled as sub-potent. An FDA warning letter in August 2020 had cited the company for out-of-specification potency.
• Acella NP Thyroid, April 2021: dozens of lots across multiple strengths were recalled as sub-potent. Acella reported 43 serious adverse event reports.

Levothyroxine has had potency recalls too, so no product is immune. The difference is the regulatory floor: approved levothyroxine products must meet stricter, FDA-reviewed potency standards.

Where the FDA stands in 2026

NDT products are marketed without FDA approval. In August 2025 the FDA sent letters to manufacturers, importers and distributors warning of enforcement action, citing inconsistent hormone levels, impurity risks and adverse event reports. The agency estimated that about 1.5 million Americans were prescribed animal-derived thyroid pills in 2024.

On March 11, 2026, the FDA replaced that position. It told manufacturers it intends to issue guidance on its compliance priorities, and separate guidance on how these products could seek approval. In the meantime, it applies a risk-based approach and may act against manufacturers that fail quality standards. As of the agency's August 2026 page update, the guidance was still described as planned. NDT remains available, but its long-term supply is uncertain. If you take it, ask your prescriber about a backup plan.

Best Thyroid Medication for Hashimoto's: Who Might Be a Candidate for T3?

For most people with Hashimoto's, the best thyroid medication is levothyroxine, taken correctly at the right dose. A T3-containing option becomes reasonable when all of the following apply:

• You have persistent hypothyroid symptoms despite a TSH in range on levothyroxine for at least several months.
• Your levothyroxine is being absorbed. That means taking it on an empty stomach, 4 hours apart from calcium and iron, with gut issues such as celiac disease or low stomach acid considered. Our celiac and thyroid guide explains why this matters.
• Other causes have been checked, including iron deficiency, B12 and vitamin D status, anemia, sleep apnea, depression and other autoimmune conditions. Our Hashimoto's fatigue guide covers this work-up.
• You are not pregnant, not trying to conceive, and do not have atrial fibrillation or significant heart disease.

People who usually should stay on levothyroxine alone include anyone pregnant or planning pregnancy, older adults with heart disease or arrhythmia, people with osteoporosis whose TSH would be pushed low, and anyone whose fatigue has a different cause still unaddressed.

If you meet the criteria, the evidence favors trying synthetic T4 plus T3 first over NDT. It uses approved drugs with consistent potency, the ratio can be set near human physiology, and in Shakir 2021 the most symptomatic patients responded at least as well to the combination as to DTE. NDT is a reasonable alternative for people who prefer it, tolerate it and accept the regulatory and supply risks. The broader menu of options, including LDN and selenium plus myo-inositol, is in our roundup of new treatments for Hashimoto's.

How to Switch Thyroid Medication Safely With Your Doctor

Switching thyroid medication is a clinical procedure, not a pharmacy swap. Doses do not convert one-to-one, and conversion charts disagree. In the Shakir 2021 protocol, 88 mcg levothyroxine was matched to 60 mg (1 grain) of DTE, or to 63 mcg levothyroxine plus 7.5 mcg liothyronine. Your prescriber may start differently based on your weight, age, heart health and current labs.

Bring specific information to the appointment: your current dose and brand, recent TSH, free T4 and free T3 results, a written symptom list scored 1 to 10, and what you have already tried. Ask what result would count as success at 3 months and what would make you both stop.

Labs to Monitor After a Switch

On levothyroxine alone, TSH is a reliable steering signal. Once T3 is in the mix, the lab picture changes and needs more careful reading.

Draw blood at the same time of day, before your thyroid dose, at the same lab. A free T3 taken 2 hours after an NDT tablet can look high and lead to an unnecessary dose cut. Our Hashimoto's lab targets guide covers the full panel, including ferritin, vitamin D and selenium.

A TSH pushed well below range for long periods carries known risks of atrial fibrillation and bone loss, particularly after 60 and after menopause. Feeling well is the goal, but not at the cost of chronic over-replacement.

Safety: Interactions, Contraindications and When to Call Your Doctor

Pregnancy. The ATA's 2017 pregnancy guideline recommends levothyroxine and advises against T3 or desiccated thyroid during pregnancy, because T4 is considered essential for the developing fetal brain (Alexander et al., 2017, Thyroid). If you take NDT or T3 and become pregnant, contact your prescriber right away. Do not stop your medication. See our Hashimoto's and pregnancy guide.

Heart conditions. Atrial fibrillation, coronary disease and older age call for slow, cautious dosing and usually favor levothyroxine alone.

Adrenal insufficiency. Thyroid hormone can precipitate an adrenal crisis if adrenal insufficiency is untreated. Cortisol replacement comes first.

Absorption interactions. Calcium, iron, magnesium, antacids, proton pump inhibitors, bile acid binders, soy and coffee can all reduce absorption of thyroid hormone. Separate thyroid medication from calcium and iron by at least 4 hours.

Lab interference. High-dose biotin, common in hair and nail supplements, can distort thyroid immunoassays. Ask your lab or doctor how long to pause it before blood work.

Call your doctor promptly if you notice: chest pain, a racing or irregular heartbeat, new shortness of breath, tremor, severe insomnia, unexplained weight loss, or a return of hypothyroid symptoms after a refill or brand change.

Cost and Insurance

Generic levothyroxine sits on the lowest tier of almost every U.S. drug plan and is one of the cheapest prescriptions available. Brand-name levothyroxine costs more, and some plans require a reason for it.

Generic liothyronine is available but is often placed on a higher tier, and some insurers ask for prior authorization. NDT products are frequently non-formulary or covered at a higher copay, and cash prices vary widely between pharmacies. Discount cards and pharmacy price comparisons can change the cost substantially. Ask your prescriber's office which option your plan covers before the prescription is written, since a mid-trial coverage problem can force an unplanned switch.

Frequently Asked Questions

Is Armour Thyroid better than levothyroxine for Hashimoto's?

Not on average. In two blinded crossover trials, symptoms, mood and memory were the same on both. Between 45% and 49% of participants preferred desiccated thyroid, and the most symptomatic patients on levothyroxine improved after switching. Levothyroxine remains the guideline first choice.

What is the difference between NDT and levothyroxine?

Levothyroxine is synthetic T4 only. NDT is dried pig thyroid containing T4 and T3 in a fixed ratio of about 4.2:1, roughly three times the T3 share of a human thyroid. Levothyroxine is FDA-approved; NDT products are not.

Is liothyronine combination therapy better than NDT?

No head-to-head trial shows one beats the other on symptoms. In Shakir 2021, the most symptomatic patients improved on both, and more of them preferred the combination. Combination therapy uses approved drugs and allows the ratio to be adjusted, so many endocrinologists try it first.

Can I take Armour Thyroid if I have Hashimoto's antibodies?

Yes. There is no published evidence that NDT raises or lowers TPO or thyroglobulin antibodies. Choose a medication for how well it replaces hormone, and address the autoimmune side separately.

How long does it take to know if a switch is working?

Plan on about 3 months. Your first lab check comes at 6 to 8 weeks, followed by dose adjustment. The ETA suggests ending a combination trial if there is no clear improvement by 3 months.

Will the FDA ban Armour Thyroid?

Not as of October 2026. The FDA signaled enforcement in August 2025, then in March 2026 said it would issue guidance on compliance priorities instead. NDT products remain on the market, but their long-term status is unresolved.

Find Your Next Step

Medication is one part of Hashimoto's care. The other part is the immune and nutrient work that standard visits often skip, covered in our evidence-based Hashimoto's protocol. Take the free 3-minute quiz to get a personalized protocol based on your condition, labs and current medications, including which questions to bring to your next endocrinology appointment.

This site provides educational information only. Not medical advice. Always consult your healthcare provider before changing your treatment plan.